scholarly journals Perception on generic drugs among general populace visiting a community pharmacy Jaipur, Rajasthan

2018 ◽  
Vol 8 (6) ◽  
pp. 192-194 ◽  
Author(s):  
Sarita Jangra ◽  
Bhupinder Bhyan ◽  
Aprna Nair
Keyword(s):  
Community Pharmacy ◽  
Healthcare Costs ◽  
Generic Drugs ◽  
Primary Source ◽  
Brand Name ◽  
Branded Drugs ◽  
The Difference ◽  
The Government ◽  
Brand Name Drugs

Healthcare costs have been leading cause of poverty for many Indians. One of the solutions to this is to advocate generic drugs which are cheaper in comparison to brand name drugs. The government of India had made it mandatory for physicians to use only generic names while prescribing. This study was conducted to analyze the perception of general public in Jaipur, Rajasthan towards generic drugs. A simple close ended questionnaire was administered to selected participants visiting a community pharmacy over a period of 3 months. Patients were asked about their opinions on effectiveness and government promotion of generic substitutions. In the study consisting of 100 participants 92 of them had heard of generic drugs while 76% knew the difference between generic and branded drugs. 47.8% believed that brand name drugs were more effective than generic while 34.7% believed in lower quality of generic drugs. Only 30.4% of participants were aware of government’s efforts to promote generic drugs. 65% confirmed that they would prefer a generic drug only if it were recommended by a physician and not a pharmacist. Majority of participants had their primary source of information as social media. The result from study suggests that in order to reduce overall healthcare costs of Indians the government must ensure to include all healthcare professionals with physicians as primary informer and also include campaigns through social Medias. Keywords: Healthcare costs, generic drugs, branded drugs, community pharmacy

Authorized generics vs. branded generics: A perspective

2020 ◽  
pp. 174113432094777
Author(s):  
Bharti Latwal ◽  
Amrish Chandra
Keyword(s):  
Lower Cost ◽  
Brand Name ◽  
Drug Companies ◽  
Generic Medications ◽  
Branded Drugs ◽  
The Masses ◽  
Brand Name Drugs ◽  
Day By Day

Nowadays, there are many generic medications available in the market. Their sale is increasing day by day due to their lower cost and affordability by most of the customers. Generic medications are pharmaceuticals that are therapeutically equivalent to an original off patent drug. Both authorized generics and branded generics are the versions of generic medications. They offer lucrative business and increase competition for ordinary generics. They supply medications having quality of branded drugs at lower prices and this establishes their recognition among the masses who earlier has limited options to buy only brand-name drugs. They are cheaper than brand name drugs but costlier than ordinary generics. Authorized generics are sold only by Innovator Companies but the branded generics can be sold by both innovator companies and generic companies. They both are different from one another and have their own impact on the brand drug companies, generic companies and consumers.

scholarly journals Improving Dementia Care Among Family Physicians: From Stigma to Evidence-Informed Knowledge

2020 ◽  
Vol 23 (4) ◽  
pp. 340-343
Author(s):  
Juanita-Dawne R. Bacsu ◽  
Farrah J. Mateen ◽  
Shanthi Johnson ◽  
Marc D. Viger ◽  
Paul Hackett
Keyword(s):  
Older Adults ◽  
Family Physicians ◽  
Primary Source ◽  
Dementia Care ◽  
Public Health Issue ◽  
Research Education ◽  
People With Dementia ◽  
The Government ◽  
Government Of Canada

Dementia is a national public health issue and a growing concern across Canada. Recently, the Government of Canada released a national dementia strategy focused on the need to prevent dementia, advance therapies, find a cure, and improve the quality of life for people with dementia. Family physicians are a primary source of care in discussing concerns of cognitive health and dementia, especially in rural and remote communities in Canada. However, research indicates that family physicians often lack knowledge and feel ill-equipped in providing care to older adults with dementia. Inadequate knowledge and education of dementia contributes to the stigmatization (stereotypes, labeling, discriminatory practices) of people with dementia and creates barriers to diagnosis and treatment. Moreover, studies show that there is dementia-related stigma among family physicians. We believe that there is a critical gap and urgent need for better dementia education and training among family physicians to improve dementia care, treatment and timely diagnosis. Thus, it is time to rethink our approach to dementia care in Canada, and to recognize that better care of older adults requires more evidence-informed research, education and interprofessional collaboration in order to reduce stigma and improve the quality of care for people with dementia.

scholarly journals Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Yuki Ito ◽  
Konan Hara ◽  
Byung-Kwang Yoo ◽  
Jun Tomio ◽  
Yasuki Kobayashi
Keyword(s):  
Generic Drugs ◽  
Income Group ◽  
High Income ◽  
Medical Expenditure ◽  
High Income Group ◽  
Brand Name ◽  
Income Groups ◽  
Additional Payment ◽  
Brand Name Drugs ◽  
Payment Rate

Abstract Background Higher income population tend to prefer brand-name to generic drugs, which may cause disparity in access to brand-name drugs among income groups. A potential policy that can resolve such disparity is imposing a greater co-payment rate on high-income enrollees. However, the effects of such policy are unknown. We examined how patients’ choice between brand-name and generic drugs are affected by the unique income-based co-payment rates in Japan; 10% for general enrollees and 30% for those with high income among the elderly aged 75 and over. Methods We drew on cross-sectional price variation among commonly prescribed 311 drugs using health insurance claims data from a large prefecture in Japan between October 2013 and September 2014 to identify between-income-group differences in responses to differentiated payments. Results Running 311 multivariate logistic regression models controlling individual demographics, the median estimate indicated that high-income group was 3% (odds ratio = 0.97) less likely to choose a generic drug than the general-income group and the interquartile estimates ranged 0.92–1.02. The multivariate feasible generalized least squares model indicated high-income group’s higher likelihood to choose brand-name drugs than the general-income group without co-payment rate differentiation (p < 0.001). Such gap in the likelihood was attenuated by 0.4% (p = 0.027) with an US$1 increase in the difference in additional payment/month for brand-name drugs between income groups — no gap with US$10 additional payment/month. This attenuation was observed in drugs for chronic diseases only, not for acute diseases. Conclusions Income-based co-payment rates appeared to reduce disparity in access to brand-name drugs across income groups, in addition to reducing total medical expenditure among high-income group who shifted from brand-name drugs to generic ones due to larger drug price differences.

scholarly journals Comparison of the Properties of Brand-Name and Generic Nadifloxacin Creams

Medicina ◽  
2011 ◽  
Vol 47 (11) ◽  
pp. 89
Author(s):  
Yutaka Inoue ◽  
Miruto Matsumoto ◽  
Masayuki Kimura ◽  
Toru Tanaka ◽  
Ikuo Kanamoto
Keyword(s):  
Water Content ◽  
Absorption Spectroscopy ◽  
Infrared Absorption ◽  
Near Infrared ◽  
Generic Drugs ◽  
Infrared Absorption Spectroscopy ◽  
Brand Name ◽  
Yield Value ◽  
Lower Viscosity ◽  
Brand Name Drugs

Background and Objective. In external preparations, types and ratios of additives are not necessarily the same for brand-name drugs and generic drugs. Thus, the physicochemical properties of preparations may differ despite the fact that they contain the same ingredients or additives. This study examined differences in brand-name and generic versions of nadifloxacin (NFX) creams. Material and Methods. Three types of NFX creams (NFX-A, NFX-B, and NFX-C) were used. The viscosity of each preparation was determined, its yield value was calculated, and each preparation was subjected to light microscopy, x-ray powder diffraction, and near-infrared absorption spectroscopy. Results. Comparison of viscosity of different preparations revealed that NFX-B had a lower viscosity than NFX-A and NFX-C (14.5 vs. 24.6 and 17.9 Pa·s). NFX-B also had a lower yield value than NFX-A and NFX-C. Microscopy revealed that NFX-A and NFX-B had satisfactory emulsification although crystallization was observed with NFX-C. Near-infrared absorption spectroscopy revealed changes in the absorption spectra of NFX-B in comparison with those of NFX-A and NFX-C that were due to differences in water content and differences in fat and oil content. Conclusions. These findings confirmed that there were differences in the viscosity and flattening of NFX-A, NFX-B, and NFX-C. In addition, microscopy revealed differences in emulsification and it revealed the precipitation of NFX crystals in NFX-C. Near-infrared absorption spectroscopy revealed that differences in the type and amount of additives and water content in the creams had contributed to differences in the preparations.

Overseas students coordinating committees ‐ the origins of student support in Australia?1

2020 ◽  
Vol 4 (1) ◽  
pp. 99-114
Author(s):  
Anna Kent
Keyword(s):  
International Students ◽  
International Education ◽  
State Government ◽  
Primary Source ◽  
Community Organizations ◽  
Student Support ◽  
Overseas Students ◽  
Australian Community ◽  
The Government

Student support in contemporary educational settings is vastly different from what it was when international education became a visible presence on Australian campuses in the 1950s. At that time, community organizations, businesses and the government cooperated to provide support to students in Australia, with little support being offered formally through universities and colleges. These Co-ordinating Committees survived for decades, into the 1990s. It could be argued that these Co-ordinating Committees facilitated a community engagement in international education that has not continued as the number of students has multiplied. Using archival and other primary source documents, this article will look at the beginnings of the Australian Organisations’ Co-ordinating Committee for Overseas Students (AOCCOS), and other similar organizations. It will analyse how the Committees changed over the decades of their existence, and what role they played in influencing government policies.The article will also investigate when and why these Committees ended, and what, if anything, has taken their place. The huge expansion of the international education sector, with more than half a million students now studying in Australia as international students, has impacted the quantity and quality of engagement with the Australian community for many of these students.Finally, the article will look at efforts to engage the community in the support of, and engagement with, international students in Australia in a more contemporary setting. This includes support provided by institutions, community and sporting organizations and state government and municipal councils.

Sign in / Sign up

Export Citation Format

Share Document